Search results for " Fat"

showing 10 items of 2011 documents

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression.

2020

Nonalcoholic fatty liver disease (NAFLD), depression, and anxiety disorders are frequent diseases, and data on mutual influence are inconsistent. The aim of this study was to explore the incidence of depression and anxiety in a large primary care cohort in Germany and to study the impact of NAFLD over a 10‐year time frame. Patients with NAFLD diagnosed between 2010 and 2015 were matched to a cohort without NAFLD controlling for age, sex, physician, index year, and Charlson comorbidity index. The primary outcome of the study was the incidence of depression, anxiety, and first prescription of antidepressant drugs. We compared 19,871 patients with NAFLD to 19,871 matched controls. Within 10 ye…

medicine.medical_specialtyHepatologybusiness.industryIncidence (epidemiology)Hazard ratioConfoundingOriginal Articlesmedicine.diseaseInternal medicineNonalcoholic fatty liver diseaseCohortMedicineAnxietylcsh:Diseases of the digestive system. GastroenterologyOriginal Articlelcsh:RC799-869medicine.symptomRisk factorbusinessDepression (differential diagnoses)Hepatology communications
researchProduct

Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.

2011

Abstract Transport across the blood–brain barrier is a relevant factor in the pharmacological action of many drugs and endogenous substances whose action site is located in brain. An overactive P-gp has been suggested to be of relevance for the resistance of the HPA system to be suppressed by glucocorticoids, which is one of the best described biological abnormalities in certain types of depression. PUFA acids have shown clinical efficacy in depressed patients and the hypothesis is that these compounds are able to reduce HPA axis activity as this effect has been shown in animal models of depression. The objective of the present work was (1) to characterize Cortisol transport through MDCK an…

medicine.medical_specialtyHydrocortisonePharmaceutical ScienceEndogenyBiologyIn Vitro TechniquesBlood–brain barrierModels BiologicalPermeabilityCell LineDogsInternal medicineAnimal models of depressionmedicineAnimalschemistry.chemical_classificationTight junctionTransporterFlow CytometryIn vitromedicine.anatomical_structureEndocrinologychemistryBlood-Brain BarrierFatty Acids UnsaturatedEffluxPolyunsaturated fatty acidEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Brains burning fat: Different forms of energy metabolism in the CNS of insects

1983

medicine.medical_specialtyInsectaDipteraBurning fatBrainGeneral MedicineMetabolismBeesBiologyBombyxLipid MetabolismMiceOxygen ConsumptionEndocrinologySpecies SpecificityBiochemistryInternal medicinemedicineAnimalsEnergy MetabolismEcology Evolution Behavior and SystematicsNaturwissenschaften
researchProduct

Leisure-time physical activity and intra-abdominal fat in young adulthood: A monozygotic co-twin control study

2016

Objective To investigate differences in abdominal fat compartments between young adult monozygotic twin pairs discordant for leisure-time physical activity. Methods Ten young adult male monozygotic twin pairs (age range 32-36 years) discordant for leisure-time physical activity during the past 3 years were systematically selected from a population-based Finnish twin cohort. Magnetic resonance image at the level of the L2-L3 intervertebral disc was used to predict intra-abdominal and subcutaneous abdominal fat masses. Dietary intake was assessed with a 4-day food diary. Results Inactive twins had 31% more intra-abdominal fat than their active co-twins (mean difference 0.52 kg, 95% CI 0.12 to…

medicine.medical_specialtyIntra-Abdominal FatEndocrinology Diabetes and MetabolismPopulationMedicine (miscellaneous)Monozygotic twin030209 endocrinology & metabolismDiet Records03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineMedicineYoung adulteducation2. Zero hungereducation.field_of_studyNutrition and Dieteticsbusiness.industry030229 sport sciencesmedicine.diseaseObesityEndocrinologyCohortbusinessBody mass indexObesity
researchProduct

Consequences of dietary omega-3 polyunsaturated fatty acid deficiency on retinal function and intraocular pressure in the rat

2009

Purpose Omega-3 polyunsaturated fatty acids (ω3) are key components in nervous structures but their dietary intakes in the overall population are often below nutritional requirements. A chronic deficiency in ω3 is recognized to be associated with functional impairment of the retina. At the opposite, ω3 supplementation is associated with a reduced risk for AMD. The consequences of ω3 deficiency on other eye structures than the retina, such as ciliary bodies, are scarce. The purpose of our study was to compare the response of the retina and ciliary bodies to dietary ω3 deficiency in terms of fatty acid profile and eye functionality. Methods Two successive generations of Lewis rats (G1 and G2)…

medicine.medical_specialtyIntraocular pressuregenetic structuresPopulationGlaucomaBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCiliary bodyInternal medicinemedicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organseducationchemistry.chemical_classificationeducation.field_of_studymedicine.diagnostic_testFatty acidRetinalGeneral Medicinemedicine.diseaseeye diseasesOphthalmologyEndocrinologymedicine.anatomical_structureBiochemistrychemistry030221 ophthalmology & optometrysense organs030217 neurology & neurosurgery[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyPolyunsaturated fatty acidElectroretinography
researchProduct

Dietary polyunsaturated fatty acids, intraocular pressure, and glaucoma

2014

Abstract Glaucoma is a progressive optic neuropathy and is the second leading cause of blindness worldwide. Estimations predict that nearly 80 million people will be affected by the disease in 2020. Increased intraocular pressure (IOP) has been recognized as a major risk factor for developing glaucoma. Although IOP-lowering agents have been shown to be effective for decreasing the progression of glaucoma, extensive research has been done to identify modifiable lifestyle factors involved in the pathogenesis of this disease. Among these factors, dietary lipids and particularly dietary polyunsaturated fatty acids (PUFAs) represent a promising approach. The aim of this chapter is to summarize t…

medicine.medical_specialtyIntraocular pressureretinagenetic structuresomega-6[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionGlaucomaDiseaseBiologyBioinformaticsoptic nerveOptic neuropathyPathogenesis03 medical and health sciences0302 clinical medicinelipidmedicineRisk factor[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs030304 developmental biologychemistry.chemical_classification0303 health sciencesmedicine.diseaseeye diseasesSurgery3. Good health[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionnutritionglaucomachemistry[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansOptic nerve030221 ophthalmology & optometrysense organsomega-3diet[SDV.AEN]Life Sciences [q-bio]/Food and NutritionPolyunsaturated fatty acidpolyunsaturated fatty acidsintraocular pressure
researchProduct

The Effects of Restriction Pressures on the Acute Responses to Blood Flow Restriction Exercise

2019

Purpose: No current guidelines or recommendations exist informing the selection of restriction pressure during blood flow restriction exercise (BFRE). Moreover, the effects of specific relative restriction pressures on the acute muscle, metabolic and cardiopulmonary responses to BFRE are unclear. The purpose of this study was to characterize these acute responses at different levels of restriction pressure. Methods: Participants (n = 10) completed rhythmic isometric knee extension exercise across five experimental trials in a balanced randomized order. Three were BFRE trials {B-40 [restriction pressure set to 40% LOP (total limb occlusion pressure)]; B-60 (60% LOP); and B-80 (80% LOP)) with…

medicine.medical_specialtyKaatsuPhysiologyIsometric exerciseElectromyography030204 cardiovascular system & hematologyverenkiertoBlood flow restrictionVascular occlusionlcsh:Physiology03 medical and health sciences0302 clinical medicineEMGInternal medicinePhysiology (medical)Heart ratemedicinelimb occlusion pressureOriginal ResearchKaatsumedicine.diagnostic_testMuscle fatiguelcsh:QP1-981business.industrySkeletal muscle030229 sport sciencesrestriction pressuremedicine.anatomical_structureelektromyografialihasmassablood flow restrictionCardiologymuscle fatiguevoimaharjoittelumedicine.symptombusinesslihasvoimaFrontiers in Physiology
researchProduct

Microscopic Endonasal Surgery for Repair of CSF Leaks

1993

This manuscript will detail our experience using a microscopic endonasal surgery (MES) approach in the repair of spontaneous, traumatic, and/or iatrogenic cerebrospinal fluid (CSF) fistula into the ethmoid and sphenoid sinuses. The location of the fistula in 22 patients was determined by a direct endoscopic or microscopic visualization, intrathecal fluorescein, or computed tomography (CT) with metrizamide. Several of these patients had been treated unsuccessfully with previous neurosurgical, intracranial, and extracranial approaches to stop the leak. The CSF fistulas in all these patients were repaired with a MES approach, packing the leak with either a septal mucosal graft, or abdominal f…

medicine.medical_specialtyLeakrhinorrheabusiness.industryFistulaFasciamedicine.diseaseSurgery03 medical and health scienceschemistry.chemical_compoundDissection0302 clinical medicinemedicine.anatomical_structureCerebrospinal fluidOtorhinolaryngologychemistry030220 oncology & carcinogenesisMetrizamidemedicineAbdominal fatmedicine.symptom030223 otorhinolaryngologybusinessAmerican Journal of Rhinology
researchProduct

Non-alcoholic fatty liver disease pathogenesis: The present and the future

2008

Non-alcoholic fatty liver disease is the clinical hepatic expression of metabolic syndrome. The prevalence of non-alcoholic fatty liver disease is around 20-30%, and with a rapid increase in the metabolic risk factors in the general population, non-alcoholic fatty liver disease has become the most common cause of liver disease worldwide. A fraction (20-30%) of non-alcoholic fatty liver disease patients develop a potentially progressive hepatic disorder, namely non-alcoholic steatohepatitis, leading to end-stage liver disease. The pathogenesis of non-alcoholic fatty liver disease is not entirely understood, and even if insulin resistance is a major pathogenetic key, many other factors are im…

medicine.medical_specialtyLipolysisPopulationPhysiologyApoptosisMitochondria LiverInsulin resistance Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis SteatosisDiseaseFatty Acids NonesterifiedPathogenesisLiver diseaseInsulin resistanceAdipokinesRisk FactorsInternal medicinemedicineAnimalsHumansGenetic Predisposition to Diseaseeducationeducation.field_of_studyHepatologybusiness.industryFatty liverGastroenterologymedicine.diseaseDietFatty LiverOxidative StressEndocrinologyAdipose TissueLiverDisease ProgressionHepatocytesCytokinesInsulin ResistanceSteatohepatitisMetabolic syndromebusinessDigestive and Liver Disease
researchProduct

Evidence-based medicine and the problem of healthy volunteers

2017

Abstract Healthy controls are subjects without the disease being studied but may have other conditions indirectly affecting outcome. In the present epidemics of obesity a few subjects with undiagnosed nonalcoholic fatty liver disease enter clinical studies as controls, producing biased results. Stricter selection criteria should be considered to prevent this risk.

medicine.medical_specialtyLiver EnzymesSpecialties of internal medicinePredictive Value of TestDiseaseGastroenterology03 medical and health sciences0302 clinical medicineClinical trialsLiver Function TestsPredictive Value of TestsReference ValuesNon-alcoholic Fatty Liver DiseaseLiver enzymeInternal medicineNAFLDHealthy volunteersNonalcoholic fatty liver diseasemedicineHumansReference ValueObesitySelection (genetic algorithm)Evidence-Based MedicineHepatologybusiness.industryLiver Function TestPatient SelectionLiver enzymeControl groupGeneral MedicineEvidence-based medicineClinical trials. Control group. Liver Enzymes. NAFLD. Obesitymedicine.diseaseObesityHealthy VolunteerHealthy VolunteersClinical trialClinical trialRC581-951030211 gastroenterology & hepatologybusiness030217 neurology & neurosurgeryHuman
researchProduct